Voxel touts FDA-cleared holography
Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95). Voxel uses a
Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95).
Voxel uses a proprietary camera to create VoxGrams, or holographicimages, that seem to reach out into space when they are viewed.Voxel believes the enhanced perspective will help clinicians whenviewing images.
Voxel will show ongoing clinical work using VoxGrams in neurologicaland breast imaging. The company plans to begin beta-site installationsof the system next year.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
